ALD403

New phase 2 data boosts prospects for Alder's migraine drug
BioPharma Dive
Mon, 03/28/16 - 06:51 pm
migraines
Alder Biopharmaceuticals
ALD403
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
FDA
Rayaldee
OPKO Health
Nuplazid
Acadia
abaloparatide
Radius Health
pegvaliase
Biomarin
ALD403
Alder Biopharmaceuticals
IPO Stock Watch: Alder Soars On Migraine Drug Results
Investors.com
Sat, 05/16/15 - 02:02 pm
IPOs
Alder Biopharmaceuticals
migraines
ALD403
3 Companies Working to Make Migraines Milder
Motley Fool
Wed, 08/7/13 - 09:36 am
migraines
Allergan
Botox
LY2951742
Eli Lilly
Arteaus Therapeutics
Merck
MK-1602
Alder Biopharmaceuticals
ALD403
Bristol-Myers Squibb